Detailed price information for Autolus Therapeutics Plc ADR (AUTL-Q) from The Globe and Mail including charting and trades.
Hilariously and without realizing it, antivaxxer Steve Kirsch nailed the essence of why a recent antivax "report" by the ...
Company reports Q3 2025 AUCATZYL® net product revenue of $21.1 million and deferred revenue of $7.6 million; 60 authorized treatment centers achieved ahead of targetClinical execution and data ...
Two oral and seven poster presentations further support the CARVYKTI® research in multiple myeloma First-in-Human Phase 1 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback